Pneumococcal disease infects about 500,000 people each year in the U.S., killing about 25,000 of them. So, in 2010, when the FDA approved Pfizer s Prevnar 13, a vaccine that prevents pneumonia and other serious diseases caused by pneumococcus, for use in children between the ages of 6 weeks and 5 years, it represented a major advance in the prevention of infectious disease.
Pneumococcal disease infects about 500,000 people each year in the U.S., killing about 25,000 of them. So, in 2010, when the FDA approved Pfizer s Prevnar 13, a vaccine that prevents pneumonia and other serious diseases caused by pneumococcus, for use in children between the ages of 6 weeks and 5 years, it represented a major advance in the prevention of infectious disease.